S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Biden To Unleash "Choke Point" Operation On America? (Ad)
Factory or farm? Oregon may alter land use for chipmakers
Travel disruption hits Germany on eve of transport strike
Bank Accounts: Frozen! (Ad)
Adele extends Las Vegas residency, plans concert film
Berlin climate proposal fails to get enough yes votes to win
Modern Day Options Trading For Beginners! (Ad)pixel
Turkmenistan votes for new, opposition-free parliament
Technical issues at Lufthansa cause delays in Frankfurt
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Biden To Unleash "Choke Point" Operation On America? (Ad)
Factory or farm? Oregon may alter land use for chipmakers
Travel disruption hits Germany on eve of transport strike
Bank Accounts: Frozen! (Ad)
Adele extends Las Vegas residency, plans concert film
Berlin climate proposal fails to get enough yes votes to win
Modern Day Options Trading For Beginners! (Ad)pixel
Turkmenistan votes for new, opposition-free parliament
Technical issues at Lufthansa cause delays in Frankfurt
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Biden To Unleash "Choke Point" Operation On America? (Ad)
Factory or farm? Oregon may alter land use for chipmakers
Travel disruption hits Germany on eve of transport strike
Bank Accounts: Frozen! (Ad)
Adele extends Las Vegas residency, plans concert film
Berlin climate proposal fails to get enough yes votes to win
Modern Day Options Trading For Beginners! (Ad)pixel
Turkmenistan votes for new, opposition-free parliament
Technical issues at Lufthansa cause delays in Frankfurt
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Biden To Unleash "Choke Point" Operation On America? (Ad)
Factory or farm? Oregon may alter land use for chipmakers
Travel disruption hits Germany on eve of transport strike
Bank Accounts: Frozen! (Ad)
Adele extends Las Vegas residency, plans concert film
Berlin climate proposal fails to get enough yes votes to win
Modern Day Options Trading For Beginners! (Ad)pixel
Turkmenistan votes for new, opposition-free parliament
Technical issues at Lufthansa cause delays in Frankfurt
OTCMKTS:ADXS

Ayala Pharmaceuticals - ADXS Stock Forecast, Price & News

$1.35
-0.15 (-10.00%)
(As of 03/24/2023 08:52 PM ET)
Add
Compare
Today's Range
$1.30
$1.40
50-Day Range
$1.30
$1.80
52-Week Range
$1.00
$10.71
Volume
1,000 shs
Average Volume
7,684 shs
Market Capitalization
$2.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ADXS stock logo

About Ayala Pharmaceuticals (OTCMKTS:ADXS) Stock

Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.

Receive ADXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADXS Stock News Headlines

Biden To Unleash "Choke Point" Operation On America?
Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
Biden To Unleash "Choke Point" Operation On America?
Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
Advaxis and Ayala Pharmaceuticals Complete Merger
Form 8-K Advaxis, Inc. For: Oct 18 - StreetInsider.com
Ayala, Advaxis Merge - Baystreet.ca
Reunion Neuroscience Names Greg Mayes As President And CEO
See More Headlines
Receive ADXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADXS Company Calendar

Last Earnings
9/09/2021
Today
3/26/2023
Next Earnings (Estimated)
6/06/2023
Fiscal Year End
10/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ADXS
Employees
14
Year Founded
2002

Profitability

Net Income
$-17,860,000.00
Pretax Margin
-6,064.80%

Debt

Sales & Book Value

Annual Sales
$3.24 million
Book Value
$21.36 per share

Miscellaneous

Free Float
1,811,000
Market Cap
$2.45 million
Optionable
Optionable
Beta
2.44

Social Links


Key Executives

  • Ken Berlin
    President, Chief Executive Officer & Director
  • Igor Gitelman
    VP-Finance, Chief Financial & Accounting Officer
  • Andres A. Gutiérrez
    Chief Medical Officer & Executive Vice President
  • Michael Grace
    Vice President-Technical Operations













ADXS Stock - Frequently Asked Questions

How have ADXS shares performed in 2023?

Ayala Pharmaceuticals' stock was trading at $1.20 on January 1st, 2023. Since then, ADXS stock has increased by 12.5% and is now trading at $1.35.
View the best growth stocks for 2023 here
.

When is Ayala Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 6th 2023.
View our ADXS earnings forecast
.

How were Ayala Pharmaceuticals' earnings last quarter?

Ayala Pharmaceuticals, Inc. (OTCMKTS:ADXS) posted its quarterly earnings results on Thursday, September, 9th. The biotechnology company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.02. The biotechnology company earned $0.25 million during the quarter.

What is Ayala Pharmaceuticals' stock symbol?

Ayala Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ADXS."

How do I buy shares of Ayala Pharmaceuticals?

Shares of ADXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ayala Pharmaceuticals' stock price today?

One share of ADXS stock can currently be purchased for approximately $1.35.

How much money does Ayala Pharmaceuticals make?

Ayala Pharmaceuticals (OTCMKTS:ADXS) has a market capitalization of $2.45 million and generates $3.24 million in revenue each year. The biotechnology company earns $-17,860,000.00 in net income (profit) each year or ($8.93) on an earnings per share basis.

How can I contact Ayala Pharmaceuticals?

Ayala Pharmaceuticals' mailing address is 305 COLLEGE ROAD EAST, PRINCETON NJ, 08540. The official website for the company is www.advaxis.com. The biotechnology company can be reached via phone at (609) 452-9813, via email at ir@advaxis.com, or via fax at 609-452-9818.

This page (OTCMKTS:ADXS) was last updated on 3/27/2023 by MarketBeat.com Staff